致癌KRAS诱导NIX介导的线粒体自噬促进胰腺癌
该研究在胰腺导管腺癌(PDAC)模型中揭示致癌KRAS诱导BNIP3L/NIX表达及选择性线粒体自噬,限制葡萄糖进入线粒体并增强氧化还原能力;Nix缺失恢复功能线粒体、增加NADPH需求并降低葡萄糖受限下的增殖,在小鼠KPC模型中显著延缓肿瘤进展并改善生存,但PanIN仍可进展为PDAC。
要点
- 致癌KRAS通过诱导NIX介导线粒体自噬限制线粒体葡萄糖通量并增强氧化还原能力。
- Nix缺失在葡萄糖受限条件下增加NADPH需求并降低细胞增殖。
- 小鼠KPC模型中Nix缺失显著延缓PDAC进展并改善生存。
核心结论
- KRAS-NIX线粒体自噬程序是PDAC糖酵解、氧化还原稳健性和疾病进展的新驱动因素。
研究设计与样本
- 研究在PDAC细胞及小鼠KPC模型中分析致癌KRAS诱导的NIX表达与线粒体自噬。
主要发现
- 致癌KRAS诱导BNIP3L/NIX表达及选择性线粒体自噬,限制葡萄糖通量进入线粒体并增强氧化还原能力。
- Nix缺失恢复功能线粒体,增加NADPH还原力需求,并在葡萄糖受限条件下降低增殖。
- 小鼠KPC模型中Nix缺失显著延缓胰腺癌进展并改善生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activating KRAS mutations are found in nearly all cases of pancreatic ductal adenocarcinoma (PDAC), yet effective clinical targeting of oncogenic KRAS remains elusive. Understanding of KRAS-dependent PDAC-promoting pathways could lead to the identification of vulnerabilities and the development of new treatments. We show that oncogenic KRAS induces BNIP3L/NIX expression and a selective mitophagy program that restricts glucose flux to the mitochondria and enhances redox capacity. Loss of Nix restores functional mitochondria to cells, increasing demands for NADPH reducing power and decreasing proliferation in glucose-limited conditions. Nix deletion markedly delays progression of pancreatic cancer and improves survival in a murine (KPC) model of PDAC. Although conditional Nix ablation in vivo initially results in the accumulation of mitochondria, mitochondrial content eventually normalizes via increased mitochondrial clearance programs, and pancreatic intraepithelial neoplasia (PanIN) lesions progress to PDAC. We identify the KRAS-NIX mitophagy program as a novel driver of glycolysis, redox robustness, and disease progression in PDAC. SIGNIFICANCE: NIX-mediated mitophagy is a new oncogenic KRAS effector pathway that suppresses functional mitochondrial content to stimulate cell proliferation and augment redox homeostasis. This pathway promotes the progression of PanIN to PDAC and represents a new dependency in pancreatic cancer.This article is highlighted in the In This Issue feature, p. 1143.
引用
- Humpton TJ, Alagesan B, DeNicola GM, et al. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer. Cancer Discov. 2019. PMID: 31263025. doi:10.1158/2159-8290.CD-18-1409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。